Reimbursement Support
Reimbursement Codes and Allowables
Reimbursement Guide
Patient Education
Prostate Diseases
  Prostate Cancer
    Chemotherapy
    Cryosurgery
    Hormone Therapy
    Radiation Therapy
    Radical Prostatectomy
    Transurethral Resection of the Prostate (TURP)
    Watchful Waiting
  Benign Prostatic Hyperplasia (BPH)
  Prostatitis
  Helpful Links
Patient FAQs
Patient Information from Package Insert
Androgen Reduction Graph
Physician Information


  Bayer Global
  Bayer Corporate - USA
general conditions of use
privacy statement
imprint
© 2007 Bayer HealthCare Pharmaceuticals

 
Physician Support
Prostate Cancer - References		    
     
 
  1. Cancer Reference Information: How Many Men Get Prostate Cancer? 2005. American Cancer Society. Available at:
    http://www.cancer.org/docroot/CRI/content/CRI_2_2_1X_
    How_many_men_get_prostate_cancer_36.asp?sitearea=&level.
    Accessed January 1, 2005.
  2. Cancer Reference Information: How Many Men Get Prostate Cancer? 2005. American Cancer Society. Available at:
    http://www.cancer.org/docroot/CRI/content/CRI_2_2_1X_
    How_many_men_get_prostate_cancer_36.asp?sitearea=&level.
    Accessed January 1, 2005.
  3. Cancer Reference Information: How Many Men Get Prostate Cancer? 2005. American Cancer Society. Available at:
    http://www.cancer.org/docroot/CRI/content/CRI_2_2_1X_
    How_many_men_get_prostate_cancer_36.asp?sitearea=&level.
    Accessed January 1, 2005.
  4. National Institutes of Health, National Cancer Institute. Understanding Prostate Changes: A Health Guide for Men, 2004, page 19.
  5. National Institutes of Health, National Cancer Institute. Understanding Prostate Changes: A Health Guide for Men, 2004, page 19.
  6. National Institutes of Health, National Cancer Institute. Understanding Prostate Changes: A Health Guide for Men, 2004, page 19.
  7. National Institutes of Health, National Cancer Institute. Understanding Prostate Changes: A Health Guide for Men, 2004, page 19.
  8. Marks, Sheldon, M.D. Prostate and Cancer: A Family Guide to Diagnosis, Treatment & Survival. Fisher Books. 1999, page 34.
  9. Marks, Sheldon, M.D. Prostate and Cancer: A Family Guide to Diagnosis, Treatment & Survival. Fisher Books. 1999, page 15.
  10. Marks, Sheldon, M.D. Prostate and Cancer: A Family Guide to Diagnosis, Treatment & Survival. Fisher Books. 1999, page 15.
  11. National Institutes of Health, National Cancer Institute, What You Need to Know About: Prostate Cancer. Available at:
    http://cancer.gov/cancertopics/wyntk/prostate/allpages.
    Accessed January 1, 2005.
  12. National Institutes of Health, National Cancer Institute, What You Need to Know About: Prostate Cancer. Available at:
    http://cancer.gov/cancertopics/wyntk/prostate/allpages.
    Accessed January 1, 2005.
  13. Marks, Sheldon, M.D. Prostate and Cancer: A Family Guide to Diagnosis, Treatment & Survival. Fisher Books. 1999, page 102.
  


Back

Important Safety Considerations
Viadur is contraindicated in patients with hypersensitivity to Gn-RH, Gn-RH agonist analogs, or any of the components in Viadur.

Viadur is contraindicated in women and pediatric patients and was not studied in women or children.

Viadur, like other LH-RH agonists, causes a transient increase in serum concentrations of testosterone during the first week of treatment. Patients may experience a worsening of symptoms or onset of new symptoms including bone pain, neuropathy, hematuria, or ureteral or bladder outlet obstruction, and spinal cord compression.

The most comment systemic side effects were hot flashes (67.9%), asthenia (7.6%), gynecomastia (6.9%), depression (5.3%), and sweating (5.3%). The most common local side effects were bruising (34.6%) and burning (5.6%).

Distributed and Marketed by:
Manufactured by:

Bayer HealthCare Pharmaceuticals
6 West Belt, Wayne, NJ 07470 USA

© Copyright 2007 Bayer HealthCare Pharmaceuticals. Viadur is a trademark of ALZA Corporation under license to Bayer HealthCare Pharmaceuticals. DUROS® is a registered trademark of ALZA Corporation.

The information provided on Bayer products is only intended for the United States audience. Regulatory requirements, regulations, laws, and distribution of information about drug products may vary from country to country. Product names and indications (product uses) also may be different in different countries. The prescribing information provided here is based on United States labeling and may not be appropriate outside of the United States.